Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,833
Closed -$1.64M 345
2024
Q1
$1.64M Sell
11,833
-462
-4% -$58.1K 0.12% 149
2023
Q4
$1.53M Sell
12,295
-97
-0.8% -$9.91K 0.12% 149
2023
Q3
$1.16M Sell
12,392
-257
-2% -$29K 0.1% 164
2023
Q2
$1.63M Buy
+12,649
New +$1.53M 0.13% 142

Other funds holding DXCM

Courier Capital's DXCM Position: Q2 2024 in Review

Courier Capital sold out of DexCom (DXCM) in Q2 2024, closing a stake of 11,833 shares — an estimated $1.64M sold.

Courier Capital first reported a position in DXCM in Q2 2023 and held it in 4 quarters. The position peaked at $1.64M in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Courier Capital reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Courier Capital sold 11,833 DexCom shares in Q2 2024, an estimated $1.64M.
  • Courier Capital first reported a position in DexCom in Q2 2023 and held it in 4 quarters.
  • Courier Capital's DexCom position peaked at $1.64M in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Courier Capital's 13F filing for Q2 2024, filed 23 Jul 2024.